Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Multiple Myeloma (MM) is an incurable malignant plasma cell disorder. We have evaluated the counts of Multiple Myeloma Cells (MMCs) and normal plasma cells (N-PCs), seven days after high-dose melphalan (HDM) and autologous stem transplantation (ASCT). Two third of patients had detectable minimal res...

Descripción completa

Detalles Bibliográficos
Autores principales: Caraux, Anouk, Vincent, Laure, Bouhya, Salahedine, Quittet, Philippe, Moreaux, Jérôme, Requirand, Guilhem, Veyrune, Jean-Luc, Olivier, Gaëlle, Cartron, Guillaume, Rossi, Jean-François, Klein, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539173/
https://www.ncbi.nlm.nih.gov/pubmed/23154454

Ejemplares similares

Ejemplares similares